HAMAD MEDICAL CORPORATION

HMC's 3rd Precision Medicine Conference focused on integrating AI and advanced technologies into clinical practice, attracting over 900 healthcare professionals. Discussions highlighted the role of genomics and AI in personalised healthcare, aiming to improve patient outcomes. Dr Abdulla al-Ansari and Dr Salha Bujassoum al-Bader emphasized the importance of collaboration and knowledge sharing to enhance patient care.

Dr Said Ismail of Qatar Precision Health Institute (QPHI) emphasizes precision medicine's potential to shift from treating diseases post-onset to focusing on predisposition, saving lives through early interventions. QPHI, launched by Qatar Foundation in 2024, implements pharmacogenomics pilots with Hamad Medical Corporation and collaborates internationally on global health challenges like Covid-19 genetics. QPHI, formed from Qatar Genome and Qatar Biobank, aims to address healthcare disparities through precision medicine, aligning with Qatar Foundation's priorities.

QPHI champions precision medicine, tailoring treatments based on individual genetic profiles, aiming to enhance treatment effectiveness and shift focus toward preventive medicine, aligning with Qatar’s Vision 2030.

QPHI unveiled a 25,000-genome dataset, enhancing research in precision health, and launched the Qatar Precision Health Research Consortium to foster multi-institutional collaboration.

The Kidney Transplant Precision Medicine Programme at Hamad Medical Corporation integrates medical genetics and kidney transplant departments to improve outcomes for high-risk patients with hereditary kidney diseases through advanced genetic testing and personalised treatment plans.

The Kidney Transplant Precision Medicine Program at Hamad Medical Corporation uses advanced genetic testing to improve outcomes for high-risk patients with hereditary kidney diseases, enhancing transplant safety and quality.

QPHI announces release of 25,000 new genomic data and research collaboration opportunities, positioning Qatar at the forefront of precision medicine.

Qatar, with its advanced healthcare system and strategic location, offers world-class medical facilities and expertise, attracting patients globally. Renowned institutions like Sidra Hospital and Aspetar lead in specialized care, while Hamad Medical Corporation integrates patient care, research, and education. Qatar's holistic approach includes seamless travel, diverse accommodations, and a supportive environment for healing.

Scientists at Weill Cornell Medicine in Qatar created a molecular map of the human body using data from 391 volunteers, integrating genomic, transcriptomic, metabolomic, and proteomic data into an interactive tool called Connecting Omics (COmics). This tool aims to investigate molecular make-up and disease associations, identifying proteins and metabolites linked to type 2 diabetes subtypes.

Scientists at Weill Cornell Medicine in Qatar created a molecular map of the human body using blood, urine, and saliva samples from 391 volunteers, integrating data into an interactive web-based tool called Connecting Omics (COmics) to investigate molecular make-up and disease traits.